<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58556">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01717534</url>
  </required_header>
  <id_info>
    <org_study_id>10.42.NRC</org_study_id>
    <nct_id>NCT01717534</nct_id>
  </id_info>
  <brief_title>Children Immune Functions</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Heat-treated Lactobacilli on Infections and Immune Status in Healthy Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <authority>Mexico: Federal Commission for Sanitary Risks Protection</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the planned study is to investigate the effect of heat-treated lactobacilli
      on diarrhea outcome in healthy children 1-4 years old in a randomized, double-blind,
      placebo-controlled study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The beneficial effect of heat-treated lactobacilli for treatment of symptomatic diarrhea was
      clearly documented and the purpose of this planned study is to investigate the effect on
      reduction of days with diarrhea in a preventive setting in healthy children 1-4 years old.
      Moreover, the study is intended to evaluate the impact on the immune status of the children.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Days with diarrhea</measure>
    <time_frame>during 5 months of study period</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of episodes of upper respiratory infections</measure>
    <time_frame>during 5 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of upper respiratory infections</measure>
    <time_frame>during 5 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of upper respiratory infections</measure>
    <time_frame>during 5 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of gastrointestinal infections</measure>
    <time_frame>during 5 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">374</enrollment>
  <condition>Diarrhea</condition>
  <condition>Upper Respiratory Infections</condition>
  <arm_group>
    <arm_group_label>Heat-treated lactobacilli</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water.
The duration of the treatment is 5 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One sachets (1 gram of content) will be consumed once a day, and will be suspended in a provided milk powder to be reconstituted with water.
The duration of the treatment is 5 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>heat-treated lactobacilli or placebo</intervention_name>
    <description>Daily supplement of sachet with 1 g of powder over a 5 months period.</description>
    <arm_group_label>Heat-treated lactobacilli</arm_group_label>
    <arm_group_label>Maltodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Parents written and signed informed consent for participation in the study: parents
             agree with the participation in the study, dated and signed informed consent form
             prior to any study related procedure.

          2. Healthy children aged 1 to 4 years

          3. No more breastfed.

          4. Daily home cared and going to a selected pediatrician.

          5. Parents must have a phone at home or a cellular phone to call the paediatrician.

          6. No consumption of commercial products containing probiotics and / or prebiotics
             during the 3 weeks before and during the study period.

          7. Children not being intensive consumers of regular yoghurts

          8. Parents are able to keep a daily record of symptoms and to administrate the study
             products.

        Exclusion Criteria:

          1. Vaccine administration within the last 3 months prior study start.

          2. Used antibiotics within the last month

          3. Congenital or chronic disease.

          4. Any kind of immunodeficiency or allergy.

          5. Acute infection or fever.

          6. Significant illness within the two weeks prior to the start of the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>48 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angeles Nava Hernández, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Clinical Research of Querétaro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos A. Mena Cedillos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Institute</name>
      <address>
        <city>Tlalnepantla</city>
        <state>Edo. De Méx</state>
        <zip>54055</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clinicos de Queretaro S.c.</name>
      <address>
        <city>Querétaro</city>
        <state>Qro</state>
        <zip>76000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 26, 2013</lastchanged_date>
  <firstreceived_date>October 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diarrhea</keyword>
  <keyword>Children</keyword>
  <keyword>Heat-treated lactobacilli</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
